News

Approvals pave way for construction as scheduled VANCOUVER, BC, — (November 28, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has received the...

Preparation and planning key to rapid approval VANCOUVER, BC, — (November 21, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has submitted architectural,...

VANCOUVER, BC, — (GLOBE NEWSWIRE – November 15, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both Israeli and European export sales, is pleased to announce that the Financial Industry Regulatory Authority,...

Expert Agronomic and Project Management Knowledge Vital to Early Success VANCOUVER, British Columbia, Nov. 14, 2019 (Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, has engaged the services of LinC by Growing...

VANCOUVER, BC, — (November 6, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) has granted a total of 3,500,000 stock options to certain officers, directors, consultants and an investor relations provider of the Company pursuant to the Company’s stock option plan. The stock options may be exercised at a price...

Company engages respected contractors with Cannabis sector experience to ensure timely acceptance by government agencies VANCOUVER, British Columbia, Nov. 05, 2019 — Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for...

Company aims to develop top regional cannabis brands for entry into EU marketplace VANCOUVER, BC, — October 28, 2019 – Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel. Concurrent to...

VANCOUVER, British Columbia, Oct. 16, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities Exchange. The Company...

VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) — Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company” or “Atlas”) wishes to advise that further to its news release dated May 21, 2019, the Canadian Securities Exchange (the “CSE”) has conditionally accepted its proposed transaction (the “Transaction”) with Isracann Biosciences Inc. (“Isracann”), which is...